Plexus Q4 GAAP and adjusted EPS guidance beats estimates
Plexus Inc has raised its Q4 guidance, beating estimates on GAAP EPS ($2.18-$2.34 vs $2.11), adjusted EPS ($2.47-$2.63 vs $2.25), and revenue ($1.330B-$1.380B vs $1.260B).

*this image is generated using AI for illustrative purposes only.
Plexus Inc (NASDAQ: PLXS) has updated its fourth-quarter financial outlook, projecting both GAAP and adjusted earnings per share to exceed analyst expectations. The electronics manufacturing services provider now forecasts GAAP EPS in the range of $2.18 to $2.34, surpassing the $2.11 estimate held by analysts. This update complements previous guidance that already indicated a beat on adjusted metrics, reinforcing confidence in the company’s profitability trajectory heading into the end of the fiscal period.
Comprehensive Q4 Outlook
The company’s latest projections indicate a significant beat on key financial metrics relative to market consensus across both non-GAAP and GAAP measures. The following table outlines the variance between Plexus’s internal guidance and external analyst estimates.
| Metric | Plexus Guidance | Analyst Estimate |
|---|---|---|
| Adjusted EPS | $2.47 - $2.63 | $2.25 |
| GAAP EPS | $2.18 - $2.34 | $2.11 |
| Sales | $1.330B - $1.380B | $1.260B |
What the Numbers Show
The divergence between Plexus’s guidance and analyst estimates suggests stronger-than-anticipated demand or margin expansion during the quarter. With the lower bound of the adjusted EPS guidance ($2.47) exceeding the analyst estimate ($2.25) by approximately 9.8%, the company appears confident in its operational efficiency. Similarly, the sales floor of $1.330 billion represents a 5.6% upside to the $1.260 billion estimate, indicating robust order fulfillment or pricing power. The new GAAP EPS guidance further validates this strength, with the midpoint of the range significantly outperforming the consensus view, suggesting that core operational gains are translating effectively to the bottom line without reliance on excessive one-time adjustments.
Which specific end-market segments are driving the unexpected 5.6% upside in sales guidance for Plexus?
How might this significant beat on GAAP EPS influence Plexus's valuation multiples relative to other EMS peers?
What operational efficiencies or cost-saving initiatives contributed to the margin expansion beyond analyst expectations?


























